Assessment of Brain Activity Associated With Inhibition of Action in Attention-deficit Hyperactivity Disorder

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Inhibitory control allows individuals to suppress unwanted actions and to resist irrelevant stimuli. It is thought to be a core deficit in Attention-deficit/hyperactivity disorder (ADHD). The present study aims at evaluating this deficit in adults with ADHD. Executive and inhibitory capacities, as well as the neural mechanisms underlying inhibitory control, will be assessed in adults with ADHD and two control groups of participants.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Age between 18 and 50,

‣ Visual, auditory (authorized apparatus), motor skills suitable for the proper realization of neuropsychological tests,

⁃ Being right-handed,

⁃ Free, informed and written consent signed by the participant and the investigator

⁃ Person affiliated or beneficiary of a social security scheme.

• For the ADHD group:

‣ Diagnosis of ADHD according to DSM-V criteria (APA, 2013),

∙ For the patient control group:

∙ • Patient who consulted for a cognitive complaint and for whom the diagnosis of ADHD was rejected according to the criteria of DSM-V (APA, 2013).

Locations
Other Locations
France
Toulouse Purpan University Hospital
RECRUITING
Toulouse
Contact Information
Primary
Jeremie PARIENTE, MD PHD
pariente.j@chu-toulouse.fr
05.61.77.95.02
Backup
Mario Hervaul, MS
Time Frame
Start Date: 2021-03-17
Estimated Completion Date: 2024-12
Participants
Target number of participants: 60
Treatments
Experimental: ADHD group
ADHD group: 20 participants having received a positive diagnosis of ADHD
Other: Control group 1
Control group 1: 20 participants having received a negative diagnosis of ADHD
Other: Control group 2
Control group 2: 20 participants as healthy volunteers
Sponsors
Collaborators: Centre National de la Recherche Scientifique, France
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov

Similar Clinical Trials